Director/PDMR Shareholding

RNS Number : 4441Q

Hutchison China Meditech Limited

09 April 2009

 



Hutchison China MediTech Limited ('Chi-Med') 

(AIM: HCM)

Director's Shareholding

London: Thursday, 9 April 2009: Chi-Med was informed today that Mr Christian Hogg, Executive Director and Chief Executive Officer of Chi-Med, purchased 50,000 ordinary shares of US$1.00 each in Chi-Med (the 'Shares') at a price of 55p each on 8 April 2009.

Following this purchase, Mr Hogg is beneficially interested in 320,000 Shares, representing approximately 0.6% of the current issued share capital of Chi-Med.  This is in addition to the 576,136 vested options held by him, representing approximately 1.1% of the current issued share capital of Chi-Med.

Ends

Enquiries

Chi-Med   Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson   Anthony Carlisle   David Dible	Telephone: [phone] [phone] [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

RDSBDGDSIBGGGCC